Related Experiment Video
Updated: Jun 24, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Agranulocytosis at first presentation of autoimmune hepatitis type-1
Arthur Shiyovich1, Lior Nesher, Rozalia Smolyakov
1Internal Medicine Department E, Soroka University Medical Center, Beer Sheva 84101, Israel. arthur.shiyovich@gmail.com
Abstract:
Autoimmune hepatitis (AIH) is a progressive, chronic disease of unknown cause with varying presenting symptoms, ranging from no symptoms through nonspecific symptoms to fulminant hepatic failure. Although nonspecific hematologic abnormalities in AIH may occur, a case of agranulocytosis (<100 neutrophils/microL) associated with a flare of AIH and suspected to be of autoimmune origin was recently reported. Increased levels of suppressing cytokines had been previously reported in bone marrow samples of patients with AIH type-1 (AIH-1). These changes could be related to induction of apoptosis or interference with differentiation and proliferation of the myeloid lineage, hence, playing a meaningful role in the pathogenesis of agranulocytosis in patients with AIH-1. Here, we report a patient with agranulocytosis at first presentation of AIH-1. On the basis of the patient's diagnostic evaluation, response to administered therapy, and the review of the literature, we suggest several possible mechanisms relating to bone marrow cytokine milieu changes, in addition to autoimmune pathogenesis, that could explain this phenomenon.
Related Concept Videos
Graves' Disease I: Introduction
Type I Diabetes I: Introduction
Graves Disease II: Pathophysiology
Viral Hepatitis I: Introduction
Type I Diabetes II: Pathophysiology
Hepatitis
